IMARA Inc.
PDE9 INHIBITORS FOR TREATMENT OF PERIPHERAL DISEASES
Last updated:
Abstract:
The present invention relates to PDE9 inhibitors, their synthesis, and their use for treatment of benign prostate hyperplasia, beta thalassemia, and sickle cell disease.
Status:
Application
Type:
Utility
Filling date:
9 Oct 2020
Issue date:
25 Mar 2021